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Abstract
Background: Sleep deprivation has been associated with obesity among adults, and accumulating data suggests
that stearoyl-CoA desaturase 1 (SCD1) expression has a relevant impact on fatty acid (FA) composition of lipid pools
and obesity. The aim of this study was to investigate the effect of one-night total sleep deprivation (TSD) on DNA
methylation in the 5’-prime region of SCD1, and whether detected changes in DNA methylation are associated
with SCD activity indices (product to precursor FA ratios; 16:1n-7/16:0 and 18:1n-9/18:0) derived from serum
phospholipids (PL).
Methods: Sixteen young, normal-weight, healthy men completed two study sessions, one with one-night TSD and
one with one-night normal sleep (NS). Sleep quality and length was assessed by polysomnography, and consisted
of electroencephalography, electrooculography, and electromyography. Fasting whole blood samples were
collected on the subsequent morning for analysis of DNA methylation and FAs in serum PL. Linear regression
analyses were performed to assess the association between changes in DNA methylation and SCD activity indices.
Results: Three CpG sites close to the transcription start site (TSS) of SCD1 (cg00954566, cg24503796, cg14089512)
were significantly differentially methylated in dependency of sleep duration (−log10P-value > 1.3). Both SCD-16 and
SCD-18 activity indices were significantly elevated (P < 0.05) following one-night TSD, and significantly associated
with DNA methylation changes of the three mentioned probes in the 5’ region of SCD1.
Conclusion: Our results suggest a relevant link between TSD, hepatic SCD1 expression and de-novo fatty acid
synthesis via epigenetically driven regulatory mechanisms.
Keywords: DNA methylation, Fatty acid composition, Monounsaturated fatty acids, Sleep condition,
Stearoyl-CoA desaturase
Background
Sleep deprivation has been associated with higher risk of
weight gain and development of obesity among children
and adults [1–3], which may provoke a higher suscepti-
bility to chronic illnesses, such as diabetes [4, 5], and
cardiovascular diseases [6, 7]. Human studies have dem-
onstrated that sleep deprivation alters the central ner-
vous system driven control of both hunger and appetite,
provoking excessive food intake [8–10]. However, the
knowledge of the complex and multifactorial mecha-
nisms between sleep duration and increased risk of
weight gain and obesity is still limited.
A recently published study has demonstrated that
rhythmic expression patterns of clock and selected
clock-controlled genes in human blood cells are in part
determined by exogenous factors, such as sleep and fast-
ing state, and in part by the endogenous circadian timing
system [11]. Furthermore, new results indicate that acute
sleep loss alters the epigenetic and transcriptional profile
of core circadian clock genes in key metabolic tissues
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[12], and that longer habitual sleep duration could
ameliorate genetic predisposition to obesity via a favor-
able dietary profile [13].
The enzyme stearoyl-CoA desaturase (SCD), which is
predominantly expressed in the liver, plays a central role
in the desaturation of saturated fatty acids (FAs), thus
having important implications in the metabolism of FAs
and development of obesity. SCD catalyzes the biosyn-
thesis of the monounsaturated FAs palmitoleate (16:1n-7)
and oleate (18:1n-9) from the saturated FAs palmitate
(16:0) and stearate (18:0), respectively [14]. In sated state
the FAs of phospholipids (PL) and triglycerides (TG) in
healthy liver originate from nonesterified FAs, dietary FAs
incorporated in chylomicrons and FAs synthesized by
hepatic de novo lipogenesis from dietary carbohydrates
[15–17]. The de-novo FA synthesis in liver is well reflected
by SCD activity indices estimated as ratios of 16:1n-7/16:0
and 18:1n-9/18:0 in blood TG as well as in PL [18–21].
Over the last decade there has been much interest in esti-
mating the SCD activity as a putative biomarker for body
fat regulation and development of obesity.
Studies have shown that there is a very tight and com-
plex regulation of SCD1 gene expression in response to
various parameters including hormonal and nutrient fac-
tors [22, 23]. Furthermore, elevated expression levels of
the human SCD1 gene are found to correlate both with
the SCD enzyme activity [24], and obesity [25].
Recently, it has been demonstrated in healthy subjects,
who have been also included in the current study that
one-night of total sleep deprivation (TSD) alters clock
gene regulation, concomitant with deleterious metabolic
effects, which are differential across key peripheral meta-
bolic tissues in healthy humans [12]. Hitherto, no study
has addressed the effect of sleep deprivation on cytosine
DNA methylation of SCD1 that might have implications
for SCD activity, endogenous lipid biosynthesis and de-
velopment of obesity. Therefore, we assessed DNA
methylation of selected CpG sites within the SCD1 pro-
moter and studied the associations with SCD activity in-
dices derived from serum PL following both one-night
normal sleep (NS) and one-night TSD in young healthy
men.
Methods
Study cohort and design
This study was based on prospectively collected data
from a randomized crossover within-subject trial de-
signed to examine the effects of one-night TSD on gene
expression and DNA methylation of core circadian clock
genes in peripheral tissues. The study was registered
with ClinicalTrials.gov, number NCT01730742. Details
of the study design have been published previously [12].
Sixteen young (age: 23.3 ± 3.4 (mean ± S.D.) years),
normal-weight (BMI: 23.64 ± 2.35 kg/m2), and healthy
men participated in two sessions of this study. In brief,
on day 1 the participants were provided standardized
meals including breakfast, lunch, snack, and dinner. The
next night nocturnal sleep was either permitted from
22:30 h (lights off ) to 06:30 h (lights on; one-night NS)
or the participants remained exposed to light under con-
stant supervision from 22:30 h to 06:30 h, remaining
bed-restricted and fasted, i.e. one-night TSD. All partici-
pants were engaged in both conditions using a within-
subject, randomized crossover design, where each condi-
tion was separated by 4 weeks. Written, informed con-
sent was obtained from all participants and the regional
ethical committee in Uppsala, Sweden approved the
study. Sleep quality and length was assessed by polysom-
nography (Embla A10, Flaga hf, Reykjavik, Iceland), and
consisted of electroencephalography, electrooculography,
and electromyography. Blood samples were collected in
EDTA tubes in the evening (19:30 h) of day 1, and in the
morning after the intervention and before a standardized
breakfast (07:30 h) of day 2. Fasting whole blood samples
for DNA methylation analysis were immediately frozen
in a 50/50 mixture of ethanol and dry ice before depos-
ited in −80 °C. Serum samples were separated from fast-
ing whole blood and stored in −80 °C before FA analysis.
Sample preparation and methylation analyses
Genomic DNA was extracted by robot assisted phenol/
chloroform extraction at the Latvian Biomedical Re-
search and Study Centre in Riga, Latvia. Bisulfite conver-
sion of DNA and hybridization to the Illumina 450 K
methylation Bead Chip (Illumina, San Diego, USA) was
performed at the Science for Life Laboratory (SciLifeLab
Uppsala, Sweden). Beta values representing the methyla-
tion status (0–100 %) of SCD1, localized on chromo-
some 10, were generated by GenomeStudio (Illumina,
San Diego, USA).
Determination of SCD-16 and SCD-18 activity
The total serum lipid fraction was extracted with
chloroform-methanol (2:1, v ⁄v), using a well-established
method [26]. PL were separated on a TLC plate using
the solvent system petroleum ether⁄diethyl ether ⁄acetic
acid (80:20:1, v⁄v⁄v). The PL FAs were methylated with
14 % boron trifluoride in methanol, and the FA methyl
esters analyzed by a HP Series II 5890, series A Gas
Chromatograph (Hewlett Packard Co⁄Agilent, Palo Alto,
CA, USA). The FA methyl esters were identified and cal-
ibrated against commercial standards (Sigma Chemical
Co.; Nu-Check-Prep, Elysian, MN, USA). The results
were expressed as percentage (%) of total FAs in serum
PL. Activity indices of SCD-16 and SCD-18 were deter-
mined calculating the ratios of 16:1n-7/16:0 and 18:1n-
9/18:0, respectively, derived from serum PL.
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Statistical analysis
Statistical analyses of methylation data were performed
with the software package R (version 3.1). Probes having
the transcription start site (TSS) of SCD1 as closest TSS
were extracted from the chip. Both upstream and down-
stream probes were included. Information about the
exact distance to the TSS was extracted according to
Price et al. [27]. A total of 19 SCD probes associated to
SCD1 were identified and used in the analysis. Pairwise
t-tests were performed to detect differences in DNA
methylation between one-night NS and one-night TSD.
Subsequently, we performed linear regression analyses
regressing TSD induced changes in probe methylation
against changes in the activity indices of SCD-16 (16:1n-
7/16:0) and SCD-18 (18:ln-9/18:0) derived from serum
PL. In all analyses the ratio of neutrophils to leukocytes
was taken into account in order to prevent shifting
monocyte subpopulations affecting the data (i.e. the
regulation of immune and inflammatory responses).
Wilcoxon signed-rank test (SPSS software, version
21.0; IBM Corporation, Somers, N.Y., USA) was used
to compare intraindividual differences in 16:1n-7/16:0
and 18:ln-9/18:0 ratios before and after the two differ-
ent sleep conditions. A P-value < 0.05 was considered
statistically significant.
Results
Effect of one-night TSD on cytosine DNA methylation
Methylation of three SCD1 probes (cg00954566,
cg24503796, cg14089512) close to the TSS was significantly
different between one-night NS and one-night TSD in un-
adjusted analyses (−log10 P-value > 1.3; Fig. 1: Left). Other
probes, although not significant, displayed a similar trend
towards hypermethylation after one-night TSD as in one-
night NS. This was especially observed for CpG sites
within 2000 bp up- or downstream of the TSS. Here, 11 of
14 probes showed a hypermethylation between 0.1 and
1.8 % after one-night TSD as in one-night NS (Fig. 1:
Right).
Association between cytosine DNA methylation and SCD
activity indices
CpG sites found to be significantly changed in their
methylation pattern after TSD were subsequently inves-
tigated in linear regression analyses regressing change of
methylation to SCD activity indices. The methylation of
three CpG sites was associated with the activity indices
of SCD-16, namely cg19191454 (positively associated,
(P < 0.001), cg23508052 and cg11311579 (negatively as-
sociated, P = 0.01 and P = 0.05, respectively) (Table 1).
Furthermore, the probe cg15022173 was negatively as-
sociated (P = 0.02), and cg07649988 positively associated
(P = 0.05) with the activity indices of SCD-18.
Fatty acid composition and SCD activity indices
There were no significant changes of the levels of the
SCD precursor and product, 16:0 and 16:1n-7, and 18:0
and 18:1n-9, respectively, in fasting serum PL following
one-night NS. However, there were significant changes of
individual FA levels, that resulted in elevated (P < 0.05)
cg00954566
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Fig. 1 DNA methylation in relation to SCD1 position. Three of 19 SCD1 probes differ significantly in DNA methylation in dependency of sleep
duration (one-night normal-sleep (NS) versus one-night total sleep deprivation (TSD); Left panel −log10 P-value). A similar trend towards hyperme-
thylation was observed for probes close to the transcription start site (TSS) (Right panel Methylated beta-value)
Skuladottir et al. Lipids in Health and Disease  (2016) 15:137 Page 3 of 7
SCD-16 and SCD-18 activity indices derived from fasting
serum PL following one-night TSD (Table 2).
Discussion
We demonstrate, for the first time to our knowledge
that one-night TSD is significantly associated with in-
creased methylation in the 5’ prime region of the SCD1
gene. Importantly, we show that one-night TSD related
methylation changes of SCD1 are significantly associated
with changes in SCD-16 and SCD-18 activity indices de-
rived from fasting serum PL followed by one-night TSD
in young normal-weight healthy men, thus, describing a
novel regulatory pathway by which TSD may influence
homeostasis of body fat.
Table 1 Association between cytosine DNA methylation and SCD activity indices following one-night total sleep deprivation
Probe ID Position Relative TSS (bp) Mean sleep % (sd) Mean wake % (sd) Slope P-value Slope P-value
Chr 10 NM_005063 SCD-16 SCD-18
(16:1n-7/16:0) (18:1n-9/18:0)
cg19191454 102106597 −175 4.4 (0.9) 4.2 (0.4) 0.016 <0.001 1.434 0.63
cg23508052 102106812 40 2.9 (0.5) 2.8 (0.5) −0.003 0.01 −0.892 0.80
cg11311579 102106755 −17 0.8 (0.2) 1.0 (0.2) −0.004 0.05 −6.887 0.38
cg01270221 102116383 9611 81.9 (1.3) 81.8 (1.2) −0.092 0.07 −0.175 0.93
cg06400428 102107667 895 11.1 (3.5) 10.6 (3.6) 0.015 0.10 0.590 0.48
cg16744911 102108975 2203 82.0 (2.2) 82.4 (1.8) 0.025 0.19 0.213 0.87
cg03440556 102107758 986 27.6 (6.2) 26.6 (6.3) 0.039 0.25 −0.298 0.69
cg12714759 102102352 −4420 21.5 (3.9) 21.4 (3.8) 0.011 0.27 0.270 0.73
cg02237755 102107926 1154 83.1 (3.3) 83.1 (3.7) 0.048 0.55 −0.591 0.48
cg15022173 102101047 −5725 76.3 (2.2) 76.9 (2.4) −0.420 0.56 −2.326 0.02
cg00653847 102100213 −6559 70.9 (4.1) 71.6 (3.5) −0.025 0.61 −0.515 0.63
cg24503796 102107677 905 13.8 (3.2) 14.5 (2.9) −0.018 0.65 0.766 0.53
cg07649988 102106577 −195 3.7 (0.7) 3.6 (0.8) −0.019 0.72 8.026 0.05
cg14089512 102106758 −14 9.6 (1.1) 10.3 (1.2) 0.048 0.75 0.180 0.92
cg07230380 102106359 −413 0.7 (0.6) 0.9 (0.5) 0.004 0.92 1.160 0.75
cg18328965 102107585 813 11.0 (1.7) 10.8 (1.8) 0.221 0.93 1.902 0.14
cg00699831 102116399 9627 87.1 (1.1) 87.2 (1.3) 0.236 0.95 2.899 0.08
cg26351966 102106081 −691 18.2 (2.9) 18.7 (3.2) 0.017 0.96 0.050 0.97
cg00954566 102106406 −366 4.4 (0.9) 4.3 (0.9) −0.002 0.97 0.474 0.90
The table shows selected SCD1 probes and SCD activity indices derived from serum phospholipids of young healthy men. Bold represents a statistically significant
association at P < 0.05; software package R (version 3.1)
Table 2 SCD activity indices before (day 1) and after (day 2) one-night normal-sleep (NS) or total sleep deprivation (TSD)
NS (n = 12) TSD (n = 14)
Day 1 Day 2 Day 1 Day 2
Fatty acids (% of total FAs)
16:0 26.78 ± 0.44 26.80 ± 0.35 26.58 ± 0.37 27.00 ± 0.24a
16:1n-7 0.41 ± 0.04 0.43 ± 0.04 0.37 ± 0.03 0.40 ± 0.02a
18:0 12.78 ± 0.34 12.00 ± 0.51 12.55 ± 0.22 12.35 ± 0.16a
18:1n-9 9.40 ± 0.33 9.54 ± 0.33 9.51 ± 0.25 9.74 ± 018a
Activity indices
SCD16 0.0150 ± 0.0014 0.0159 ± 0.0014 0.0140 ± 0.0009 0.0147 ± 0.0009a
(16:1n-7/16:0)
SCD18 0.7641 ± 0.0351 0.8088 ± 0.0367 0.7591 ± 0.0198 0.7904 ± 0.0170a
(18:1n-9/18:0)
The table shows the SCD activity indices derived from serum phospholipids of young healthy men
Data are expressed as mean ± SEM
aP < 0.05 compared with day 1, Wilcoxon signed-rank test
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Recently it was demonstrated in the subjects of the
present study, that a one-night TSD alters the epigenetic
and transcriptional profile of core circadian clock genes
in key metabolic tissues [12], thus demonstrating TSD
systematic changes in methylation of functionally im-
portant gene networks. Increased DNA methylation has
been, in many cases, associated with a suppressed gene
expression [28]. We show that one night TSD is associ-
ated with increased methylation in the 5’ prime region
of the SCD1, which is in line with a recent study showing
that methylation shifts are able to suppress or enhance
gene expression, suggesting two different mechanisms of
DNA methylation-dependent gene regulation [29]. Our
findings that SCD1 methylation differs between one-night
NS and one-night TSD strongly support the hypothesis
that TSD is connected to epigenetic shifts that might have
impact on lipid metabolism [30].
It is known from several experimental studies that
changes in the activity of SCD indices estimated from
plasma or tissues are accompanied by simultaneous
changes in the transcriptional level of the SCD1 [31, 32].
The regulation of SCD1 gene is of considerable physio-
logical importance, as a high SCD activity has been im-
plicated in a wide range of disorders including diabetes,
atherosclerosis, cancer, and obesity [14, 33, 34]. Thus,
our observation, that one-night TSD is associated with
increased methylation of the SCD1, may allow the
speculation that TSD has the ability to contribute to the
mentioned metabolic diseases via changes in the methy-
lation pattern of genes, such as SCD1.
Short sleep duration may increase obesity risk by
causing small changes in eating patterns that cumula-
tively alter energy balance [35, 36]. Several studies have
indicated associations between insufficient sleep and al-
terations in circulating hormones involved in feeding
behavior, glucose metabolism, hunger, and appetite,
which are probably involved in the development of
metabolic disorders, such as obesity and diabetes [9,
10]. Recent study has shown that higher habitual sleep
variability, but not habitual sleep duration, is signifi-
cantly associated with abdominal obesity in adolescents,
which can be partially explained by increased caloric in-
take, especially from carbohydrates [37]. The precise
mechanism through which the brain regulates changes
in hormone release with sleep deprivation is unknown,
but one possibility is increased sympathetic nervous sys-
tem activity [38].
Several studies have reported that diet affects the FA
composition of serum PL [39–41]. Our observation indi-
cates similar dietary habits and lifestyle factors such as
cigarette smoking and alcohol consumption among the
participants, since there was no significant difference
found in FA levels of non-fasting serum PL between the
two sleep conditions separated by 4 weeks (day 1). On
the other hand, there is no general agreement which
blood lipid fraction to use regarding the assessment of
hepatic SCD activity indices. The majority of PL synthe-
sis occurs in the endoplasmic reticulum of the liver,
where PL associates with other lipids and proteins
resulting in lipoproteins that are released into the blood-
stream. Thus, we assume that in fasting blood the SCD-
16 and SCD-18 activity indices derived from serum PL
may mainly reflect hepatic SCD-1 activity. We observed
significantly elevated SCD-16 and SCD-18 activity indices
derived from fasting serum PL following one-night TSD
and before a standardized breakfast. This strengthens the
hypothesis that shortened sleep is an additional link to the
dysregulation in energy metabolism that might impact on
lipid metabolism and weight gain [30, 42].
This study is limited by its relatively small sample size
of healthy individuals, which may preclude enough
power to assess the interaction between SCD1 methyla-
tion and sleep deprivation. Another limitation of our
study is that the methylation of SCD1 was measured
only at a single time point, i.e., under fasting condition
in the morning following each sleep intervention. Thus,
conclusions about the causality have to be made care-
fully. However, our observations allow to suggesting a
role of sleep duration and quality in regulating SCD1 ex-
pression and development of obesity.
Conclusions
Our study results indicate that one-night TSD modifies
SCD1 methylation, FA levels of serum PL, and, thereby,
changes in SCD-16 and SCD-18 activity indices. The
exact mechanism how sleep restriction is implicated in
SCD1 expression and development of obesity warrants
further investigation.
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